Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorDESMONDE, S.
dc.contributor.authorCIARANELLO, A. L.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMALATESTE, Karen
dc.contributor.authorMUSICK, B.
dc.contributor.authorPATTEN, G.
dc.contributor.authorVU, A. T.
dc.contributor.authorEDMONDS, A.
dc.contributor.authorNEILAN, A. M.
dc.contributor.authorDUDA, S. N.
dc.contributor.authorWOOLS-KALOUSTIAN, K.
dc.contributor.authorDAVIES, M. A.
dc.contributor.authorLEROY, V.
dc.date.accessioned2021-03-08T11:04:59Z
dc.date.available2021-03-08T11:04:59Z
dc.date.issued2020-11-26
dc.identifier.issn1473-5571 (Electronic) 0269-9370 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26452
dc.description.abstractEnOBJECTIVE: To measure mortality incidence rates (IR) and incidence rate ratios (IRR) in adolescents and youth living with perinatally-acquired HIV (YPHIV) compared to those living with non-perinatally-acquired HIV (YNPHIV), by region, by sex, and during the ages of 10-14, 15-19, and 20-24 years in IeDEA. DESIGN AND METHODS: All those with a confirmed HIV diagnosis, antiretroviral therapy (ART)-naive at enrollment, and who have post-ART follow-up while aged 10-24 between 2004-2016 were included. We estimated post-ART mortality IRs and 95% confidence intervals (95%CI) per 100 person-years (PY) for YPHIV (enrolled into care <10 years of age) and YNPHIV (enrolled ≥ 10 years and < 25 years). We estimate mortality IRRs in a negative binomial regression model, adjusted for sex, region time-varying age, CD4 count at ART initiation (<350 cells/μL, ≥350 cells/μL, unknown), and time on ART (<12 months, ≥12 months). RESULTS: Overall, 104,846 adolescents and youth were included: 21,340 (20%) YPHIV (50% female) and 83,506 YNPHIV (80% female). Overall mortality IRs were higher among YNPHIV (IR: 2.3/100PY; 95%CI: 2.2-2.4) compared to YPHIV (IR: 0.7/100PY; 95%CI: 0.7-0.8). Among adolescents aged 10-19 years, mortality was lower among YPHIV compared to YNPHIV (all IRRs < 1, ranging from 0.26, 95%CI: 0.13-0.49 in 10-14-year-old males in the Asia-Pacific to 0.51, 95%CI: 0.30-0.87 in 15-19-year-old males in West Africa). CONCLUSION: We report substantial amount of deaths occurring during adolescence. Mortality was significantly higher among YNPHIV compared to YPHIV. Specific interventions including HIV testing and early engagement in care are urgently needed to improve survival among YNPHIV.
dc.language.isoENen_US
dc.title.enAge-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus non-perinatally-acquired HIV
dc.title.alternativeAIDSen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1097/QAD.0000000000002765en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed33252479en_US
bordeaux.journalAIDS. Official journal of the international AIDS Societyen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamIDLICen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03162126
hal.version1
hal.date.transferred2021-03-08T11:05:03Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=AIDS.%20Official%20journal%20of%20the%20international%20AIDS%20Society&amp;rft.date=2020-11-26&amp;rft.eissn=1473-5571%20(Electronic)%200269-9370%20(Linking)&amp;rft.issn=1473-5571%20(Electronic)%200269-9370%20(Linking)&amp;rft.au=DESMONDE,%20S.&amp;CIARANELLO,%20A.%20L.&amp;MALATESTE,%20Karen&amp;MUSICK,%20B.&amp;PATTEN,%20G.&amp;rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record